Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

NCT02859402 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

T-cell Non-Hodgkin Lymphoma
Lymphoma, Extranodal NK-T-Cell

Interventions

DRUG: Busulfan
DRUG: Fludarabine

Sponsor

Keimyung University Dongsan Medical Center

Collaborators

[object Object]